Maven Securities’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,000
Closed -$1.15M 609
2025
Q2
$1.15M Sell
3,000
-500
-14% -$180K 0.03% 410
2025
Q1
$1.21M Buy
3,500
+500
+17% +$161K 0.04% 397
2024
Q4
$900K Sell
3,000
-1,100
-27% -$384K 0.02% 439
2024
Q3
$1.67M Sell
4,100
-1,000
-20% -$366K 0.03% 387
2024
Q2
$1.64M Buy
+5,100
New +$1.66M 0.04% 409
2023
Q4
Sell
-30,600
Closed -$7.53M 1043
2023
Q3
$7.53M Buy
30,600
+27,300
+827% +$7.47M 0.09% 131
2023
Q2
$1M Buy
+3,300
New +$917K 0.02% 444
2022
Q2
Sell
-2,000
Closed -$501K 981
2022
Q1
$501K Sell
2,000
-2,600
-57% -$653K 0.02% 538
2021
Q4
$1.18M Buy
4,600
+1,200
+35% +$294K 0.03% 296
2021
Q3
$825K Sell
3,400
-2,200
-39% -$538K 0.03% 512
2021
Q2
$1.16M Buy
+5,600
New +$1.14M 0.05% 386

Other funds holding HCA

Maven Securities's HCA Position: Q1 2025 in Review

Maven Securities sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 2,645 shares — an estimated $851K sold.

Maven Securities first reported a position in HCA in Q2 2021 and held it in 4 quarters. The position peaked at $2.68M in Q3 2023. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Maven Securities reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 2,645 HCA Healthcare shares in Q1 2025, an estimated $851K.
  • Maven Securities first reported a position in HCA Healthcare in Q2 2021 and held it in 4 quarters.
  • Maven Securities's HCA Healthcare position peaked at $2.68M in Q3 2023.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.